From 15-17 May 2019, the EPAD project hosted its annual General Assembly meeting in Geneva (Switzerland). We were delighted that the event brought together EPAD delegates to discuss progress, latest developments and future plans. In attendance were scientists, researchers, representatives from pharmaceutical companies, patient organisations, SMEs, EPAD study site members, other experts and research participants…
This month, we get to know the Karolinska Institutet centre behind EPAD. The team of Miia Kivipelto (principal investigator of the EPAD project in Karolinska Institutet) began recruiting in August 2017 and has currently recruited 32 participants in the EPAD Longitudinal Cohort Study (LCS). We caught up with her team and asked them a few…
On 4 April, the CHU de Toulouse (CHUT) hosted the first meeting of the Research Participant Panel of the European Prevention of Alzheimer’s Dementia Consortium (EPAD) in France. We caught up with a French Research participant to know what it is like to take part in a research study and find out about his experiences.…
The mathematical modelling of disease progression is an essential part of several projects of the Innovative Medicine Initiative (IMI), namely AETIONOMY, EPAD, RADAR-AD; and it is subject of an entire work package in the European H2020 project VirtualBrainCloud. The joint interest in mathematical modelling of disease progression prompted us to come together for a first…
What is your current role in EPAD? I am an active member of the Recruitment Core Team, which includes looking at how to increase recruitment by reaching out to sites where necessary and troubleshooting problems as they occur. I am also the country coordinator for Scotland’s TDCs and I am an expert blinded rater for the CDR in…
What is your current role in EPAD? I am a co-lead of Work Package 2 – The Statistical Engine Room. The Statistical Work Package has two main focuses in the EPAD project – the design of the proof-of-concept platform trial and the disease modeling work from the Longitudinal Cohort Study (LCS). I have been focused…
The fourth Scottish Dementia Research Consortium (SDRC) conference was held in Glasgow on 15 April 2019. The annual SDRC conference showcased the world-leading dementia research taking place across Scotland and focused on early career researchers with this year’s theme being the fundamental sciences. It was an excellent conference with a variety of talks and posters…
Professor Craig Ritchie, of the University of Edinburgh, is jointly leading the EPAD project, a Europe-wide collaboration aiming to improve the understanding of the early stages of Alzheimer’s disease. EPAD combines knowledge and expertise from 39 European partner organisations across multiple sectors. Craig Ritchie and one of the EPAD study participants Eileen Penman have recently been…
On 2 April, the Innovative Medicines Initiative (IMI) organised a Projects Communication Event, which brought together more than 70 representatives from many IMI projects responsible for communications. Several members of the EPAD project travelled to Brussels to take part in this exciting event and shared their experiences within our WP6 on Dissemination. The aim of…
Fundació ACE – Barcelona Alzheimer Treatment & Research Center, an entity devoted to the diagnosis, treatment, research and awareness on Alzheimer’s disease, has been incorporated into EPAD (European Prevention of Alzheimer’s Dementia Consortium), a European consortium aiming to work for the prevention of Alzheimer’s dementia through an interdisciplinary research program. Facing the evidence that Alzheimer’s…
